TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Aros Forskning & Friskvård AB
Closing information (x1000 NOK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
417
|
306
|
181 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
638
|
247
|
92 |
| EBITDA |
260
|
247
|
92 |
| Total assets |
966
|
770
|
561 |
| Current assets |
63
|
216
|
106 |
| Current liabilities |
103
|
75
|
34 |
| Equity capital |
863
|
686
|
518 |
| - share capital |
103
|
101
|
95 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
89.3%
|
89.1%
|
92.3% |
| Turnover per employee |
417
|
306
|
181 |
| Profit as a percentage of turnover |
153.0%
|
80.7%
|
50.8% |
| Return on assets (ROA) |
66.0%
|
32.1%
|
16.4% |
| Current ratio |
61.2%
|
288.0%
|
311.8% |
| Return on equity (ROE) |
73.9%
|
36.0%
|
17.8% |
| Change turnover |
105
|
112
|
-50 |
| Change turnover % |
34%
|
58%
|
-22% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.